Global Dermal Filler Cannula Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Dermal Filler Cannula Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

A dermal Filler Cannula is a tube that can be inserted into the body for injecting dermal fillers, often for the delivery or removal of fluid or for the gathering of data.

Market Overview:

The latest research study on the global Dermal Filler Cannula market finds that the global Dermal Filler Cannula market reached a value of USD 71.89 million in 2022. It’s expected that the market will achieve USD 103.66 million by 2028, exhibiting a CAGR of 6.29% during the forecast period.

Influence of COVID-19 Outbreak on Dermal Filler Cannula Industry Development

Since the outbreak of the COVID-19 virus in December 2019, the disease has spread to nearly 100 countries around the world, and the World Health Organization has declared it an emergency public health event. The COVID-19 epidemic is infected with a large number of people, and its spread and scope far exceed SARS. At present, the number of confirmed cases in Worldwide has exceeded 29 million. Different industries are affected differently by the epidemic situation. The impact on Dermal Filler Cannula is mainly reflected in the supply of material and operation of the market. Affected by the COVID-19 epidemic, logistics will be suspended and the supply of Dermal Filler Cannula will be tight. Due to the global threat of COVID-19, the resumption of work in the factory will directly affect the customer's production plan for goods and shipments. The continuous outbreak of the international epidemic situation, if the personnel control of each country is extended, it will affect the smooth supply of equipment and materials.

For the operation of the market, during the COVID-19 epidemic, in order to firmly prevent the spread of epidemics, governments have promulgated measures to extend vacations, delay business recovery, flow control and traffic control measures, and postpone recovery activities. COVID-19 has a huge impact on the operation of the industry, of which the impact on SMEs is more obvious. The company's inability to conduct normal operations and sales has exacerbated the shortage of funds for SMEs and reduced the company's solvency.

Drivers

China's medical aesthetics has a large consumer population. With the change of Chinese medical aesthetics consumption concepts, the increase in per capita disposable income, the improvement of medical aesthetics technology and the increasing popularity of micro-plastic surgery, the large market penetration rate, and the mature policy supervision and other favorable factors, China's medical beauty market has maintained substantial growth for several consecutive years.

From the perspective of policy supervision, China's medical beauty industry has achieved hierarchical management. On December 28, 2016, China Plastic Surgery Association's 2016 medical beauty institution evaluation work summary meeting was held, announcing the birth of the first batch of 5A medical plastic surgery institutions in China. On January 20, 2017, China Association of Plastic Surgery and Cosmetology issued the Administrative Measures for the Evaluation of Medical Cosmetology Institutions and the Implementation Rules for the Evaluation Standards of Medical Cosmetology Institutions (2017 version) notice, indicating that the medical beauty industry will carry out hierarchical management, and the choice of cosmetic hospitals will be available. On May 27, 2017, seven ministries and commissions including the General Office of the National Health and Family Planning Commission and the General Office of the Food and Drug Administration jointly issued the Notice on Launching a Special Operation to Severely Combat Illegal Medical Beauty, which was decided from May 2017 to April 2018 Jointly launch a special operation to crack down on illegal medical beauty. This provides a good guarantee system for the development of China's medical beauty market.

Secondly, from the perspective of medical project management, with the increase of non-surgical projects in the global medical cosmetology market, injection filling projects are favored in China, and the public's awareness of beauty is becoming stronger, and the demand for plastic surgery is increasing day by day. This will increase the demand for medical beauty equipment such as Dermal Filler Cannula to a certain extent.

Region Overview:

Europe had the highest growth rate of all regions.

Company Overview:

The top three companies are TSK, Cosmofrance (DermaSculpt) and Aesthetic Group with the revenue market share of 25.02%, 17.19% and 9.76% in 2019.

TSK Group was established in 1948 and has three different production bases in Japan and global offices in Japan, Canada, the Netherlands, China and other places. At their facilities, they dedicate ourselves to apply the highest quality standards, from product development to production, in order to ensure the safety of every patient that is being treated with their products. All facilities and ISO certified cleanrooms pass the highest level of inspection and auditing standards, incorporated by major overseas pharmaceutical companies, medical companies and authorities.

Since its inception in 1997, CosmoFrance has been manufacturing, importing and distributing high-quality medical devices catering to US aesthetic practitionners. They specialize in innovative Non-Invasive procedures, constantly looking for the next trend that will set their customers' practice apart.

Segmentation Overview:

By type, Flexibility Cannula segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Beauty Care segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Dermal Filler Cannula market covered in Chapter 3:

Cosmofrance (DermaSculpt)
Dino Medical Instruments
Eclipse Aesthetics
Soft Medical Aesthetics
TSK
Sterimedix
Aesthetic Group

In Chapter 4 and Chapter 14.2, on the basis of types, the Dermal Filler Cannula market from 2018 to 2029 is primarily split into:

Flexibility Cannula
Rigidity Cannulas

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Dermal Filler Cannula market from 2018 to 2029 covers:

Beauty Care
Surgery

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)